BackCompass Therapeutics Overview

Compass Therapeutics Property, Plant & Equipment

Track Compass Therapeutics's PP&E ($8.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
PPE
$8.71M
↓ 12.28% YoYΔ $-1.22M vs prior year quarter

Peer trimmed avg / median

Loading

Compass Therapeutics PPE History

Loading

Compass Therapeutics vs. peers: PPE Comparison

Loading

Compass Therapeutics PPE Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Compass Therapeutics (CMPX) FAQ

The latest PP&E for CMPX is $8.7M as of June 2026. That compares with $9.9M in the prior-year period — down 12.3% year over year. Investors often review this figure alongside Compass Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CMPX's PP&E moved from $9.9M to $8.7M — a 12.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Compass Therapeutics's operating scale or balance-sheet position.

A PP&E figure of $8.7M for CMPX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CMPX's PP&E ($8.7M), review year-over-year change from $9.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Compass Therapeutics's PP&E against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.